Download

Download Full Text (273 KB)

Description

Problem: Over the past decade, direct oral anticoagulants (DOACs) have become the medication of choice for treatment of atrial fibrillation, thrombosis, and some coronary artery disease states. Prescribing these medications is often associated with inaccurate dosing leading to increased risk of bleeding and clotting events. Events related to DOAC medications have led the Joint Commission to create a National Patient Safety Goal as of July 2019, aiming to reduce the likelihood of patient harm associated with the use of anticoagulant therapy. A meta-analysis of 18 DOAC studies found that on average, prescribing errors or inappropriate dosing occurred in 20% of patients. These errors can lead to bleeding, clotting and overall increase in mortality. Currently monitoring for dosing errors is limited at Henry Ford Health.

Publication Date

3-12-2024

Publisher

Henry Ford Health

City

Detroit, Michigan

Keywords

Quality Expo, posters, poster competition

Project #17: Addressing Safety Issues with Direct Oral Anticoagulants

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.